Free Cardiology CME

  • FREE

    Misdiagnosis of hypertrophic cardiomyopathy – The HCM Academy

    This case study features expert discussion surrounding a real HCM patient and is designed to raise disease awareness and provide you with a practical understanding of how HCM can be diagnosed and appropriately managed.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 12/27/2021
    • Expiration of CME credit: 12/27/2022
  • FREE

    Primary prevention of sudden cardiac death – pediatric example – The HCM Academy

    This case study features expert discussion surrounding a real HCM patient and is designed to raise disease awareness and provide an understanding of the risk factors for sudden cardiac death in pediatric HCM patients.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 12/27/2021
    • Expiration of CME credit: 12/27/2022
  • FREE

    Signs, symptoms and the differential diagnosis of hypertrophic cardiomyopathy – The HCM Academy

    This online learning module is designed to raise awareness for HCM and provide an understanding of how HCM can be diagnosed and appropriately managed. 

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 11/02/2021
    • Expiration of CME credit: 11/02/2022
  • FREE

    Therapies for symptomatic hypertrophic cardiomyopathy patients – The HCM Academy

    This case study features expert discussion surrounding a real HCM patient and is designed to raise awareness for best practice treatment of symptomatic patients with obstructive HCM and provide you with an understanding of how heart failure symptoms should be managed.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 12/27/2021
    • Expiration of CME credit: 12/27/2022
  • FREE

    Treatment for heart failure symptoms and atrial fibrillation – The HCM Academy

    This online learning module is designed to raise awareness for HCM and provide an understanding of how HCM progresses over time and the associated mortality.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 11/02/2021
    • Expiration of CME credit: 11/02/2022
  • FREE

    Transthyretin amyloidosis (ATTR): Prompt diagnosis contemporary management strategies and their impact on patient outcomes

    Activity Description / Statement of Need:

    In this online, self-learning activity:

    Transthyretin amyloidosis (ATTR) is a progressive, multisystem, life-threatening disorder characterized by the extracellular deposition of misfolded, insoluble amyloid fibrils. The role of the TTR protein is to transport thyroxine and retinol-binding proteins, and it is vital for cognition, nerve regeneration, and axonal growth. TTR itself is innately amyloidogenic even without the presence of genetic mutations, which may account for wild-type ATTR (wtATTR), while a hereditary form of ATTR (hATTR) may be passed to offspring through autosomal dominant inheritance. Left untreated, the average life expectancy of ATTR is 3 to 15 years from symptom onset.

    This accredited educational activity would identify the critical components of the management process and offer solutions to close gaps in diagnosis and care, with the ultimate goals being the improvement of ATTR management, treatment adherence when applicable, and health and cost outcomes. 

    Target Audience:

    The following HCPs: neurologists, cardiologists, and hematologists; physician assistants, nurse practitioners, and pharmacists in the aforementioned areas of specialty; and any other HCPs with an interest in or who may clinically encounter patients with ATTR.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 12/29/2021
    • Expiration of CME credit: 12/29/2023
  • FREE

    Hereditary transthyretin amyloidosis (ATTR) treatment strategies: best practices and emerging therapies

    Activity Description / Statement of Need:

    In this online, self-learning activity:

    Transthyretin amyloidosis (ATTR) is a progressive, multisystem, life-threatening disorder characterized by the extracellular deposition of misfolded, insoluble amyloid fibrils. As TTR is a protein present in human serum, and its role is to transport thyroxine and retinol-binding proteins, it is vital for behavior, cognition, nerve regeneration, and axonal growth. TTR itself is innately amyloidogenic even without the presence of genetic mutations. The familial variant of the disease (hATTR) is ATTR that is passed to offspring through autosomal dominant inheritance, whereas the wild type variant (wtATTR) refers to ATTR that occurs independently of genetic mutations. hATTR may present as late as mid-adulthood, but its symptoms usually start between the ages of 2 and 10 years. Left untreated, the average life expectancy of ATTR is 3 to 15 years from symptom onset.

    Target Audience:

    The following HCPs: neurologists, cardiologists, and hematologists; physician assistants, nurse practitioners, nurses, and pharmacists in the aforementioned areas of specialty; and any other HCPs with an interest in or who may clinically encounter patients with ATTR.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 07/02/2021
    • Expiration of CME credit: 07/01/2023
  • FREE

    Present and novel approaches to treating heart failure with reduced ejection fraction (HFrEF): Where to start and next-line strategies

    Activity Description / Statement of Need:

    In this online, self-learning activity:

    Heart failure (HF) is a clinical syndrome arising from diminished ventricular filling or ejection of blood. HF with reduced ejection fraction (HFrEF) is characterized by abnormality in the systolic function and a left ventricular ejection fraction (LVEF) of <40%. The prevalence of HF is about 40 million people globally and approximately 6.5 million in the U.S., and as the global population continues to age, the prevalence of HF is expected to continue increasing over the coming decades. HFrEF constitutes a major public health concern, with five-year survival rates as low as 25%, and it carries with it a significant risk of emergency department visits and hospitalizations.

    There has been increased focus recently on guideline-directed medical therapy (GDMT) in HFrEF, and evidence suggests that each ten percent improvement in measures of guideline-recommended composite care is associated with a thirteen percent lower odds of 24-month mortality. Nonetheless, research shows that substantial portions of patients are not treated with guideline-recommended doses, even after taking into account dose-limiting physiological parameters, and that guideline non-adherent practice is associated with poorer outcomes.

    Target Audience:

    The following HCPs: Cardiologists and PCPs; physician assistants, nurse practitioners, and pharmacists who practice in cardiology; and any other HCPs with an interest in or who clinically encounter patients with HFrEF.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Material last updated: 05/06/2022
    • Expiration of CME credit: 05/06/2024